EFFEX Trademark

Serial Number: 79336047 • Registration: 7033247

EFFEX is a trademark filed by Katholieke Universiteit Leuven, privaatrechtelijk rechtspersoon KU Leuven Research & Development on January 24, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Katholieke Universiteit Leuven, privaatrechtelijk rechtspersoon KU Leuven Research & Development (2 trademarks)

Waaistraat 6 Bus 5105
Leuven B-3000 , BE

Entity Type: 99

Trademark Details

Filing Date

January 24, 2022

Registration Date

April 25, 2023

Published for Opposition

February 7, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 4, 2023 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Aug 4, 2023 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 4, 2023 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 25, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 25, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 25, 2023 R.PR
NOTIFICATION PROCESSED BY IB
Feb 7, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 7, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 18, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 18, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2022 TROA
REFUSAL PROCESSED BY IB
Jul 13, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 23, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jun 23, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 4, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jun 3, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 29, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 17, 2022 REPR